{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ZOSTAVAX&page=2", "query": { "intervention": "ZOSTAVAX", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ZOSTAVAX&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-09T04:18:07.164Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03993717", "title": "Solid Organ Transplant SHINGRIX", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Kidney Transplant; Complications" ], "interventions": [ { "name": "SHINGRIX", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 2, "start_date": "2020-01-30", "completion_date": "2020-08-08", "has_results": false, "last_update_posted_date": "2024-02-20", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03993717" }, { "nct_id": "NCT04128189", "title": "Shingrix in Renal Transplant Recipients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney Transplant Recipient Response to Shingrix Vaccine", "Kidney Failure", "Kidney Failure, Chronic", "Kidney Transplantation", "Herpes Zoster (HZ)" ], "interventions": [ { "name": "Shingrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 132, "start_date": "2023-03-02", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 4, "location_summary": "Aurora, Colorado • Atlanta, Georgia • Boston, Massachusetts + 1 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04128189" }, { "nct_id": "NCT04523246", "title": "Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Herpes Zoster", "Allergy and Immunology", "Corona Virus Infection" ], "interventions": [ { "name": "SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted)", "type": "BIOLOGICAL" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "65 Years to 100 Years" }, "enrollment_count": 217, "start_date": "2020-09-01", "completion_date": "2023-05-19", "has_results": false, "last_update_posted_date": "2023-11-22", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT04523246" }, { "nct_id": "NCT05007041", "title": "Simultaneous RZV and aIIV4 Vaccination", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain", "Quality of Life", "Injection Site Reaction", "Adverse Drug Event" ], "interventions": [ { "name": "FLUAD® Quadrivalent", "type": "BIOLOGICAL" }, { "name": "Fluzone® High-Dose Quadrivalent", "type": "BIOLOGICAL" }, { "name": "SHINGRIX®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 267, "start_date": "2021-09-21", "completion_date": "2023-06-08", "has_results": true, "last_update_posted_date": "2024-07-11", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Durham, North Carolina", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05007041" }, { "nct_id": "NCT01954251", "title": "Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Zoster" ], "interventions": [ { "name": "Herpes Zoster vaccine GSK 1437173A", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 829, "start_date": "2013-10-03", "completion_date": "2015-03-20", "has_results": true, "last_update_posted_date": "2018-05-02", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Carnegie, Pennsylvania • Erie, Pennsylvania", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Carnegie", "state": "Pennsylvania" }, { "city": "Erie", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01954251" }, { "nct_id": "NCT05170399", "title": "Vaccine Responses in Patients With B Cell Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "AREXVY, ABRYSVO", "type": "DRUG" }, { "name": "PREVNAR 20", "type": "DRUG" }, { "name": "PNEUMOVAX 23", "type": "BIOLOGICAL" }, { "name": "Heplisav -B", "type": "BIOLOGICAL" }, { "name": "PREVNAR 13", "type": "BIOLOGICAL" }, { "name": "Shingrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 350, "start_date": "2022-09-14", "completion_date": "2036-11-15", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05170399" }, { "nct_id": "NCT04169009", "title": "Persistence of Protection by Shingrix", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Herpes Zoster" ], "interventions": [ { "name": "Zostavax", "type": "BIOLOGICAL" }, { "name": "Shingrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 105, "start_date": "2020-07-28", "completion_date": "2024-06-13", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04169009" }, { "nct_id": "NCT06397768", "title": "Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "RSV Immunization" ], "interventions": [ { "name": "RSVt vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Streptococcus pneumoniae vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, and rubella vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella virus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Months to 12 Months" }, "enrollment_count": 2226, "start_date": "2024-05-13", "completion_date": "2025-09-18", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Grand Bay, Alabama • Mobile, Alabama + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Grand Bay", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06397768" }, { "nct_id": "NCT00007501", "title": "Shingles Prevention Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Zoster", "Postherpetic Neuralgia" ], "interventions": [ { "name": "Varicella-zoster vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 38456, "start_date": "1998-11", "completion_date": "2011-02", "has_results": false, "last_update_posted_date": "2013-07-04", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Palo Alto, California • San Diego, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00007501" }, { "nct_id": "NCT06581575", "title": "A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Herpes Zoster (HZ)", "Infectious Diseases", "Shingles" ], "interventions": [ { "name": "JCXH-105", "type": "BIOLOGICAL" }, { "name": "Shingrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Immorna Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 467, "start_date": "2024-10-16", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-09-09T04:18:07.164Z", "location_count": 8, "location_summary": "Tucson, Arizona • Long Beach, California • Chicago, Illinois + 5 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Jersey City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06581575" } ] }